BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 24780638)

  • 1. Use of propofol for short duration procedures in children with long chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) or trifunctional protein (TFP) deficiencies.
    Martin JM; Gillingham MB; Harding CO
    Mol Genet Metab; 2014 Jun; 112(2):139-42. PubMed ID: 24780638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of earlier versus later dietary management in long-chain 3-hydroxyacyl-CoA dehydrogenase or mitochondrial trifunctional protein deficiency: a systematic review.
    Fraser H; Geppert J; Johnson R; Johnson S; Connock M; Clarke A; Taylor-Phillips S; Stinton C
    Orphanet J Rare Dis; 2019 Nov; 14(1):258. PubMed ID: 31730477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of optimal dietary therapy upon visual function in children with long-chain 3-hydroxyacyl CoA dehydrogenase and trifunctional protein deficiency.
    Gillingham MB; Weleber RG; Neuringer M; Connor WE; Mills M; van Calcar S; Ver Hoeve J; Wolff J; Harding CO
    Mol Genet Metab; 2005; 86(1-2):124-33. PubMed ID: 16040264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency and progressive retinopathy: one case report followed by ERGs, VEPs, EOG over a 17-year period.
    Rigaudière F; Delouvrier E; Le Gargasson JF; Milani P; Ogier de Baulny H; Schiff M
    Doc Ophthalmol; 2021 Jun; 142(3):371-380. PubMed ID: 33392894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatal pitfalls in newborn screening for mitochondrial trifunctional protein (MTP)/long-chain 3-Hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency.
    Lotz-Havla AS; Röschinger W; Schiergens K; Singer K; Karall D; Konstantopoulou V; Wortmann SB; Maier EM
    Orphanet J Rare Dis; 2018 Jul; 13(1):122. PubMed ID: 30029694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deregulation of mitochondrial functions provoked by long-chain fatty acid accumulating in long-chain 3-hydroxyacyl-CoA dehydrogenase and mitochondrial permeability transition deficiencies in rat heart--mitochondrial permeability transition pore opening as a potential contributing pathomechanism of cardiac alterations in these disorders.
    Cecatto C; Hickmann FH; Rodrigues MD; Amaral AU; Wajner M
    FEBS J; 2015 Dec; 282(24):4714-26. PubMed ID: 26408230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RETINAL PHENOTYPE IN A CASE OF LCHAD/TFP DEFICIENCY WITH LATE-STAGE DIAGNOSIS.
    Knowles JA; Dimopoulos IS; MacDonald IM
    Retin Cases Brief Rep; 2019 Summer; 13(3):279-282. PubMed ID: 28301411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of higher dietary protein intake on energy balance and metabolic control in children with long-chain 3-hydroxy acyl-CoA dehydrogenase (LCHAD) or trifunctional protein (TFP) deficiency.
    Gillingham MB; Purnell JQ; Jordan J; Stadler D; Haqq AM; Harding CO
    Mol Genet Metab; 2007 Jan; 90(1):64-9. PubMed ID: 16996288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accumulation of 3-hydroxy-fatty acids in the culture medium of long-chain L-3-hydroxyacyl CoA dehydrogenase (LCHAD) and mitochondrial trifunctional protein-deficient skin fibroblasts: implications for medium chain triglyceride dietary treatment of LCHAD deficiency.
    Jones PM; Butt Y; Bennett MJ
    Pediatr Res; 2003 May; 53(5):783-7. PubMed ID: 12621125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The molecular basis of pediatric long chain 3-hydroxyacyl-CoA dehydrogenase deficiency associated with maternal acute fatty liver of pregnancy.
    Sims HF; Brackett JC; Powell CK; Treem WR; Hale DE; Bennett MJ; Gibson B; Shapiro S; Strauss AW
    Proc Natl Acad Sci U S A; 1995 Jan; 92(3):841-5. PubMed ID: 7846063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-chain 3-hydroxy fatty acids accumulating in long-chain 3-hydroxyacyl-CoA dehydrogenase and mitochondrial trifunctional protein deficiencies uncouple oxidative phosphorylation in heart mitochondria.
    Tonin AM; Amaral AU; Busanello EN; Grings M; Castilho RF; Wajner M
    J Bioenerg Biomembr; 2013 Feb; 45(1-2):47-57. PubMed ID: 23065309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Variation of long-chain 3-hydroxyacyl CoA dehydrogenase DNA methylated modification and correlation with gene mRNA expression of early-onset preeclampsia, HELLP syndrome and antiphospholipid syndrome in trophoblast cells of placenta].
    Meng R; Yang Z; Wang HL; Han YW; Wang YL; Yu H
    Zhonghua Fu Chan Ke Za Zhi; 2016 Apr; 51(4):270-8. PubMed ID: 27116985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Variation of long-chain 3-hydroxyacyl-CoA dehydrogenase DNA methylation in placenta of different preeclampsia-like mouse models].
    Han Y; Yang Z; Ding X; Yu H; Yi Y
    Zhonghua Fu Chan Ke Za Zhi; 2015 Oct; 50(10):740-6. PubMed ID: 26675572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial bioenergetics deregulation caused by long-chain 3-hydroxy fatty acids accumulating in LCHAD and MTP deficiencies in rat brain: a possible role of mPTP opening as a pathomechanism in these disorders?
    Tonin AM; Amaral AU; Busanello EN; Gasparotto J; Gelain DP; Gregersen N; Wajner M
    Biochim Biophys Acta; 2014 Sep; 1842(9):1658-67. PubMed ID: 24946182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient-Specific Induced Pluripotent Stem Cell-Derived RPE Cells: Understanding the Pathogenesis of Retinopathy in Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency.
    Polinati PP; Ilmarinen T; Trokovic R; Hyotylainen T; Otonkoski T; Suomalainen A; Skottman H; Tyni T
    Invest Ophthalmol Vis Sci; 2015 May; 56(5):3371-82. PubMed ID: 26024122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic control during exercise with and without medium-chain triglycerides (MCT) in children with long-chain 3-hydroxy acyl-CoA dehydrogenase (LCHAD) or trifunctional protein (TFP) deficiency.
    Gillingham MB; Scott B; Elliott D; Harding CO
    Mol Genet Metab; 2006; 89(1-2):58-63. PubMed ID: 16876451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal dietary therapy of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency.
    Gillingham MB; Connor WE; Matern D; Rinaldo P; Burlingame T; Meeuws K; Harding CO
    Mol Genet Metab; 2003 Jun; 79(2):114-23. PubMed ID: 12809642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variability in the clinical management of fatty acid oxidation disorders: results of a survey of Canadian metabolic physicians.
    Potter BK; Little J; Chakraborty P; Kronick JB; Evans J; Frei J; Sutherland SC; Wilson K; Wilson BJ
    J Inherit Metab Dis; 2012 Jan; 35(1):115-23. PubMed ID: 21630065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of bezafibrate in two patients with mitochondrial trifunctional protein deficiency.
    Suyama T; Shimura M; Fushimi T; Kuranobu N; Ichimoto K; Matsunaga A; Takayanagi M; Murayama K
    Mol Genet Metab Rep; 2020 Sep; 24():100610. PubMed ID: 32509533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial fatty acid beta-oxidation in the human eye and brain: implications for the retinopathy of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency.
    Tyni T; Paetau A; Strauss AW; Middleton B; Kivelä T
    Pediatr Res; 2004 Nov; 56(5):744-50. PubMed ID: 15347768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.